Cemtrex Inc. (NASDAQ:CETX) recently announced in an 8-K filing that it has regained compliance with the minimum stockholder’s equity requirements for continued listing on The Nasdaq Capital Market.

(Nasdaq: PBM) (“Psyence Biomed” or the ... has regained compliance with all applicable Nasdaq continued listing requirements. As previously announced, Psyence Biomed requested to be ...

Psyence Biomedical (PBM) announced that it has received notice from the Nasdaq Hearings panel that the Company has regained compliance with all applicable Nasdaq continued listing requirements.

Shares of N2Off Inc. (NITO) rose in morning trade on Wednesday after the company received a 180-day extension from the Nasdaq ...

In what will likely mark the final outcome, the U.S. Court of Appeals for the Fifth Circuit, sitting en banc, struck down the ...

OneMedNet (ONMD) regained compliance with Nasdaq Listing Rule 5250(c)(1) based on the filing of its periodic reports on Form 10-Q for the fiscal quarters ended March 31, June 30 and September 30 ...

The Nasdaq Composite increased 243.30 points or 1.2% to close at 19,864.98, also booking back-to-back gains. The tech-heavy ...

(Nasdaq: IBKR) has reportedly announced an increase in margin requirements for MicroStrategy Inc. (Nasdaq: MSTR) products, ...

The press release also contains forward-looking statements regarding IceCure Medical (TASE:PMCN)'s expectations for continued listing and compliance with Nasdaq requirements. However, these ...

BOSTON, Jan. 7, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced ...